NewGenIvf Group Ltd (NIVF) research

NewGenIvf Group Ltd

Sector: Healthcare
Industry: Medical Care Facilities
Last price: $0.13
As of: 2026-10-02

NewGenIvf Group Ltd (NIVF): 2 institutional managers tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 6-K filed 2026-09-30.

As of 2026-09-30, the latest of: this ticker's 13F holdings load, its latest SEC filing date, and its latest signal other than 13F-derived signals. Source: SEC EDGAR filings for NIVF. Method and limitations.

COMPANY DOSSIER

See the full NIVF dossier

Price with insider and filing markers, who is positioning, fundamentals and peers for NIVF on one page. Preview it with sample data, then open it live with a free account.

Preview the NIVF dossier

Active signals for NIVF

No recent signals on NIVF in the last 180 days.

FREE, NO ACCOUNT

Every signal on NIVF, as it fires

New filings, 13F moves and cross asset signals on NIVF land in the record first.

Get it by email

No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.

Join on Telegram

One tap. Live alerts, no email needed.

Largest reported share positions in NIVF (2026Q2)

Manager / security	Market value	% portfolio	QoQ
D. E. Shaw & Co., Inc.CUSIP G0544E113 · 2026Q2	$4K	0.00%	,
CITADEL ADVISORS LLCCUSIP G0544E113 · 2026Q2	$705.00	0.00%	,

Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.

Recent SEC filings, NIVF

6-K2026-09-30
SEC EDGAR ↗
6-K2026-08-18
SEC EDGAR ↗
6-K2026-08-17
SEC EDGAR ↗
6-K2026-07-31
SEC EDGAR ↗
6-K2026-07-30
SEC EDGAR ↗
6-K2026-07-27
SEC EDGAR ↗
6-K2026-07-06
SEC EDGAR ↗
6-K2026-07-01
SEC EDGAR ↗
6-K2026-06-22
SEC EDGAR ↗
6-K2026-06-18
SEC EDGAR ↗

NIVF against its peers

NIVF's operating margin of -226.9% ranks in the 14th percentile of 17 Medical Care Facilities sub-industry peers, fiscal periods ending between 2025-06-30 and 2025-12-31.

Metric	NIVF	Peer median	Percentile	n
Revenue FY	4.7M USD	29.8M USD	24	18
Revenue YoY	-13.0%	n/a	n/a	2
Gross margin	20.2%	22.7%	50	6
Operating margin	-226.9%	-12.8%	14	17
Net margin	209.0%	-16.4%	97	18
Return on equity	37.1%	-42.7%	85	9

Peers (19): FCHS, FOXO, RHEP, BMGL, BICX, CDIX, HLYK, AMS, SYRA, ADIA, CCM, GBCS, EHSI, PIII, CCEL, BTMD, DCGO, JYNT, AIRS. Left out: PAIYY (period gap), XCRT (no annual filing), PARK (no annual filing), WW (no annual filing), HWAIF (no annual filing), BACK (no annual filing). Fiscal periods ending between 2025-06-30 and 2025-12-31. Every figure is one full fiscal year read from one annual filing (NIVF: 20-F), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.

Related tickers

See more NIVF signals as they fire

Kresmion publishes filings, 13F flows, on-chain whale activity, and cross-asset signals in real time. Open a live board scoped to NIVFand get the insider, 13F, options, and confluence read in one view.